	US 11,883,447 B2
	Methods and probiotic compositions for the treatment of metabolic diseases and disorders
Mirko Trajkovski, Geneva (CH); Claire Chevalier, Geneva (CH); and Melis Çolakoglu, Geneva (CH)
Assigned to Research Development Foundation, Carson City, NV (US)
Filed by Research Development Foundation, Carson City, NV (US)
Filed on Sep. 18, 2020, as Appl. No. 17/025,811.
Claims priority of provisional application 63/069,458, filed on Aug. 24, 2020.
Claims priority of provisional application 62/902,076, filed on Sep. 18, 2019.
Prior Publication US 2021/0077549 A1, Mar. 18, 2021
Int. Cl. A61K 35/747 (2015.01); C12N 1/20 (2006.01); A61P 3/00 (2006.01)

CPC A61K 35/747 (2013.01) [A61P 3/00 (2018.01); C12N 1/20 (2013.01)]

37 Claims

1. A method for treating a metabolic disease or disorder in a mammalian subject, comprising administering a composition to the gastrointestinal system of the subject, wherein the composition comprises the therapeutically effective amount of inactivated Parabacteroides goldsteinii.